Cardiovascular Systems In... (CSII)
NASDAQ: CSII
· Real-Time Price · USD
20.00
0.03 (0.15%)
At close: Apr 27, 2023, 10:00 PM
Cardiovascular Systems Revenue Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coronary Revenue | 23M | 20.89M | 21.77M | 18.85M | 20.23M | 19.36M | 23.23M | 20.98M | 20.21M | 17.61M | 11.87M | 18.55M | 20.75M | 18.96M | 19.96M | 18.16M | 15.97M | 15.03M |
| Coronary Revenue Growth | +10.11% | -4.03% | +15.47% | -6.83% | +4.50% | -16.65% | +10.73% | +3.78% | +14.77% | +48.37% | -36.00% | -10.63% | +9.46% | -5.00% | +9.91% | +13.71% | +6.23% | n/a |
| Peripheral Revenue | 38.45M | 38.78M | 40.73M | 37.37M | 38.9M | 39.01M | 47.76M | 42.3M | 43.96M | 42.93M | 30.68M | 42.63M | 47.58M | 45.53M | 48.28M | 45.15M | 44.24M | 41.23M |
| Peripheral Revenue Growth | -0.86% | -4.78% | +8.99% | -3.94% | -0.27% | -18.32% | +12.92% | -3.78% | +2.39% | +39.95% | -28.04% | -10.41% | +4.50% | -5.69% | +6.92% | +2.07% | +7.29% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 56.33M | 55.03M | 57.49M | 51.84M | 55.47M | 55.04M | 67.29M | 59.59M | 61.91M | 58.83M | 40.45M | 58.12M | 65.96M | 61.53M | 65.7M | 60.9M | 58.6M | 54.92M |
| United States Revenue Growth | +2.37% | -4.28% | +10.89% | -6.54% | +0.78% | -18.21% | +12.92% | -3.74% | +5.23% | +45.43% | -30.40% | -11.88% | +7.20% | -6.34% | +7.88% | +3.93% | +6.69% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 41.64M | 44.48M | 46.59M | 41.68M | 40.4M | 41.85M | 45.71M | 41.44M | 40.06M | 40.28M | 34.97M | 41.38M | 46.87M | 46.75M | 43.99M | 41.36M | 41.11M | 41.24M | 37.85M | 37.8M | 37.01M | 35.92M | 35.91M | 37.33M | 33.99M | 36.87M | 37.55M | 42.34M | 41.26M | 41.4M | 38.27M | 39.35M |
| Selling, General, and Administrative Revenue Growth | -6.37% | -4.55% | +11.79% | +3.16% | -3.46% | -8.45% | +10.31% | +3.45% | -0.55% | +15.20% | -15.51% | -11.70% | +0.25% | +6.27% | +6.38% | +0.61% | -0.33% | +8.97% | +0.13% | +2.13% | +3.03% | +0.04% | -3.82% | +9.82% | -7.79% | -1.82% | -11.31% | +2.62% | -0.33% | +8.17% | -2.75% | n/a |
| Research and Development Revenue | 9.53M | 9.06M | 8.77M | 9.05M | 8.87M | 10.02M | 9.24M | 13.16M | 9.6M | 9.05M | 11.84M | 9.96M | 10.79M | 10.77M | 9.53M | 9.28M | 7.24M | 7.42M | 6.72M | 7.33M | 6.4M | 6.31M | 6.34M | 5.43M | 5.8M | 5.33M | 6.04M | 5.75M | 7.21M | 6.94M | 7.96M | 7.78M |
| Research and Development Revenue Growth | +5.27% | +3.23% | -3.08% | +2.02% | -11.46% | +8.40% | -29.77% | +37.10% | +6.06% | -23.55% | +18.83% | -7.62% | +0.20% | +13.02% | +2.62% | +28.24% | -2.41% | +10.39% | -8.37% | +14.65% | +1.40% | -0.49% | +16.70% | -6.43% | +8.81% | -11.66% | +5.06% | -20.23% | +3.82% | -12.83% | +2.39% | n/a |